Dxgen Corp.
Exhibitors
Information
We are a leading Korean biotech company specializing in quantitative diagnostics for chronic, inflammatory, and infectious diseases.
Our mission is to develop innovative point-of-needs diagnostic solutions that deliver lab-quality performance at an affordable price. We aim to serve a wide range of healthcare providers, including point-of-care sites, as well as small- and mid-sized labs and clinics.
Our unique flow-through technology offers significant advantages over conventional FIA systems, including faster assay times, superior accuracy and precision, minimal variance, and highly reliable results.
We offer a focused yet essential test menu—HbA1c, CRP, U-Albumin, D-Dimer, Glycated Albumin, and TSH—with two analyzer models. Our products directly compete with Nycocard, Afinion, DCA Vantage, Hemocue, Quo-Lab, LabonaCheck A1c, and other FIA-based systems such as i-Chroma, FineCare, Getein, and F200.
Strategically designed to meet the needs of both healthcare professionals and patients, our products will enhance your sales and marketing capabilities, particularly in the small- and mid-sized lab and clinic sectors.
